Gujarat Kidney Shares Soar 6% on Debut; Experts Advise Long-Term Hold

• Gujarat Kidney and Super Specialty Limited shares listed at a 6% premium on December 30, exceeding grey market expectations.
• The IPO, subscribed 5.21 times, saw shares open at ₹120 on NSE and ₹120.75 on BSE against an IPO price of ₹114.
• Funds raised will be used for acquiring Parekhs Hospital in Ahmedabad and Ashwini Medical Centre.
• Expert Ravi Singh highlights India's hospital sector growth, projected to reach ₹8,200 billion by FY2026, driven by healthcare needs and government schemes.
• Gujarat Kidney's focus on affordable treatment and integrated services makes it attractive for long-term investment.

Why It Matters: Gujarat Kidney's strong listing and strategic growth plans make it a promising long-term healthcare investment.